Covered recipient · General Payments record
JENNIFER ROSE PIERCE
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$2,885.75
- Reported across 195 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $467.21 | 29 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $224.19 | 16 |
| Lilly USA, LLC | $68.88 | 4 |
| Novo Nordisk AS | $38.66 | 2 |
| Amgen Inc. | $34.74 | 2 |
| Sumitomo Pharma America, Inc. | $28.27 | 1 |
| Medtronic, Inc. | $19.18 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $19.18 | 1 |
| GlaxoSmithKline, LLC. | $17.42 | 1 |
| PFIZER INC. | $16.69 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (29)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $4.34 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107850373 | CMS |
| ABBVIE INC. | $9.56 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107850375 | CMS |
| ABBVIE INC. | $10.14 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107850377 | CMS |
| ABBVIE INC. | $20.37 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107850379 | CMS |
| ABBVIE INC. | $7.60 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107850381 | CMS |
| ABBVIE INC. | $10.56 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107850383 | CMS |
| ABBVIE INC. | $7.13 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107850385 | CMS |
| ABBVIE INC. | $20.78 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107850387 | CMS |
| ABBVIE INC. | $14.69 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107850389 | CMS |
| ABBVIE INC. | $7.45 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107850391 | CMS |
| ABBVIE INC. | $4.77 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107850393 | CMS |
| ABBVIE INC. | $34.98 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107850395 | CMS |
| ABBVIE INC. | $7.06 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107850397 | CMS |
| ABBVIE INC. | $20.24 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107850399 | CMS |
| ABBVIE INC. | $21.49 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107850401 | CMS |
| ABBVIE INC. | $23.03 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107850403 | CMS |
| Amgen Inc. | $18.47 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117656103 | CMS |
| Amgen Inc. | $16.27 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117656105 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $19.18 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086353434 | CMS |
| GlaxoSmithKline, LLC. | $17.42 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116604346 | CMS |
| Lilly USA, LLC | $22.34 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135684827 | CMS |
| Lilly USA, LLC | $13.38 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135644558 | CMS |
| Lilly USA, LLC | $16.47 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135644560 | CMS |
| Lilly USA, LLC | $16.69 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135656525 | CMS |
| Medtronic, Inc. | $19.18 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116943214 | CMS |
| Novo Nordisk Inc | $17.81 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100487679 | CMS |
| Novo Nordisk Inc | $20.85 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100473371 | CMS |
| PFIZER INC. | $16.69 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131921709 | CMS |
| Sumitomo Pharma America, Inc. | $28.27 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148988152 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.